Original Research
Published on 05 Jul 2021
The 13-Valent Pneumococcal Conjugate Vaccine Elicits Serological Response and Lasting Protection in Selected Patients With Primary Humoral Immunodeficiency
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2021.697128
- 6,129 views
- 8 citations

